2016
DOI: 10.1093/cid/ciw635
|View full text |Cite
|
Sign up to set email alerts
|

2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

Abstract: Background. Circulating A/H3N2 influenza viruses drifted significantly after strain selection for the 2014-2015 vaccines. Also in 2014-2015, the Advisory Committee on Immunization Practices recommended preferential use of live attenuated influenza vaccine (LAIV) over inactivated influenza vaccine (IIV) among children aged 2-8 years.Methods. Vaccine effectiveness (VE) across age groups and vaccine types was examined among outpatients with acute respiratory illness at 5 US sites using a test-negative design, tha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
203
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 249 publications
(223 citation statements)
references
References 22 publications
11
203
0
1
Order By: Relevance
“…However, this difference was not observed in the 2014-2015 U.S. Flu VE Network Study which had more influenza cases with repeated vaccination and single season vaccination than the other two studies combined [13].…”
Section: H3n2mentioning
confidence: 77%
See 2 more Smart Citations
“…However, this difference was not observed in the 2014-2015 U.S. Flu VE Network Study which had more influenza cases with repeated vaccination and single season vaccination than the other two studies combined [13].…”
Section: H3n2mentioning
confidence: 77%
“…Eighteen studies met the eligibility criteria [4,13,[16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31]. Of these, one study was restricted to hospitalized patients and was therefore excluded from the meta-analysis [31].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…As influenza evolves from year to year, antigenic differences between previously and currently circulating strains contribute to low vaccine efficacy [1][2][3][4] and high incidence of influenza illness [2,5]. While vaccines regularly undergo reformulation to address this mismatch, vaccines may also affect antigenic evolution.…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, in 2014-2015, LAIV effectiveness against A(H3N2) virus was 11% (95%CI D -1, 21) and against B virus (Yamagata lineage) was 54% (95% CI D 41, 64). 35 In our serology data, to the extent that LAIV was eliciting an immune response (i.e., B lineages), it was significantly and inversely associated with vitamin D levels. Small sample size among the IIV recipients may have masked a similar response to this form of the vaccine.…”
Section: Discussionmentioning
confidence: 62%